Fierce JPM Week 2022 (Virtual Dates)
The long haul: How pharma and healthcare can thrive in 2022 We might have thought the COVID-19 pandemic would be over by year-end 2021, but experts now say—and the omicron variant suggests—the virus will likely always be with us. What pandemic lessons has the industry learned that can help tackle longtime challenges—such as speeding up drug...